Speaker:
Target Audience
This activity is intended for physicians, physician assistants, advanced practice nurses, general practitioners and other health care professionals involved in the treatment and management of patients who have or are at risk of HIV infection.
Learning Objectives
Upon completion of theactivity, participants should be better able to:
Joint Accreditation Statement:
 In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical
Education and ViralEd, Inc. Partners for Advancing Clinical
Education is jointly accredited by the Accreditation Council for Continuing Medical
Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing
Center (ANCC), to provide continuing education for the healthcare team |
Physician Continuing Medical Education:
Partners for Advancing Clinical Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Professional Development:
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hours.
Pharmacy Continuing Education:
Partners for Advancing Clinical Education designates this continuing medical education for 1.0 contact hour(s)(0.1 CEUs) of the Accreditation Council for Pharmacy Education.
PA Continuing Medical Education:
Partners for Advancing Clinical
Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should claim only the credit commensurate with the extent of their participation.
Disclosure of Conflicts of Interest
Partners for Advancing Clinical Education requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary buisness is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners for Advancing Clinical Education policies. Others involved in the planning of this activity have no relevant financial interests.
Helena Kwakwa, MD
Partners for Advancing Clinical Education
The Partners for Advancing Clinical Education planners and others have nothing to disclose. The ViralEd, Inc. planners and others have nothing to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
